Trellus Health Plc Stock Revenue
| TRLS Stock | 0.57 0.00 0.00% |
Trellus Health plc fundamentals help investors to digest information that contributes to Trellus Health's financial success or failures. It also enables traders to predict the movement of Trellus Stock. The fundamental analysis module provides a way to measure Trellus Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Trellus Health stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 19 K | 16.5 K |
Trellus | Revenue |
Trellus Health plc Company Revenue Analysis
Trellus Health's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Trellus Health Revenue | 19 K |
Most of Trellus Health's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Trellus Health plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Trellus
Projected quarterly revenue analysis of Trellus Health plc provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Trellus Health match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Trellus Health's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Trellus Total Revenue
Total Revenue |
|
Based on the latest financial disclosure, Trellus Health plc reported 19 K of revenue. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The revenue for all United Kingdom stocks is 100.0% higher than that of the company.
Trellus Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Trellus Health's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Trellus Health could also be used in its relative valuation, which is a method of valuing Trellus Health by comparing valuation metrics of similar companies.Trellus Health is currently under evaluation in revenue category among its peers.
Trellus Fundamentals
| Return On Equity | -0.35 | ||||
| Return On Asset | -0.23 | ||||
| Operating Margin | (81.08) % | ||||
| Current Valuation | (5.49 M) | ||||
| Shares Outstanding | 161.51 M | ||||
| Shares Owned By Insiders | 47.46 % | ||||
| Shares Owned By Institutions | 17.40 % | ||||
| Price To Book | 0.07 X | ||||
| Price To Sales | 16.88 X | ||||
| Revenue | 19 K | ||||
| Gross Profit | 25 K | ||||
| EBITDA | (5.85 M) | ||||
| Net Income | (6.8 M) | ||||
| Total Debt | 786 K | ||||
| Book Value Per Share | 0.1 X | ||||
| Cash Flow From Operations | (5.27 M) | ||||
| Earnings Per Share | (0.03) X | ||||
| Target Price | 0.24 | ||||
| Beta | 0.15 | ||||
| Market Capitalization | 928.67 K | ||||
| Total Asset | 20.29 M | ||||
| Retained Earnings | (21.81 M) | ||||
| Working Capital | 11.54 M | ||||
| Net Asset | 20.29 M |
About Trellus Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Trellus Health plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Trellus Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Trellus Health plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Trellus Stock Analysis
When running Trellus Health's price analysis, check to measure Trellus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trellus Health is operating at the current time. Most of Trellus Health's value examination focuses on studying past and present price action to predict the probability of Trellus Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trellus Health's price. Additionally, you may evaluate how the addition of Trellus Health to your portfolios can decrease your overall portfolio volatility.